Dietrich John Pauls - President & CEO, Director at DiaMedica Therapeutics Inc.

Issuer-level insider activity

Role
President & CEO, Director
Issuer ticker
DMAC on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Dietrich John Pauls since 19 Sep 2025

Reported holdings for Dietrich John Pauls in DiaMedica Therapeutics Inc.

Form 4 holding President & CEO, Director

DiaMedica Therapeutics Inc.

Security class
Voting Common Shares, no par value per share
Shares / value
68,591
Estimated value
$192,055
Report date
01 Jun 2024
Price
$2.80
Ownership
Direct

Transaction history for Dietrich John Pauls in DiaMedica Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .